Philippe Bensimon is listed as an executive officer on 7 SEC Form D filings by 1 issuer between Nov 2017 and Oct 2026: CollPlant Biotechnologies Ltd (Rehovot, Israel (as filed: L3) — other health care — 2017–2026; $10.4M reported sold to 14 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Abraham Havron (7 shared filings), Eran Rotem (7 shared filings), Yehiel Tal (7 shared filings), Elan Penn (6 shared filings), Joseph Zarzewsky (6 shared filings) and 19 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Philippe. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 7 public filings for Philippe Bensimon and found 2 differences: No amendment in the last 12 months on an offering that may still be open; Address moved from Ness-Ziona, Israel (as filed: L3) to Rehovot, Israel (as filed: L3).
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
